|
|
|
|
| LEADER |
00000cam a2200000 c 4500 |
| 001 |
1669005364 |
| 003 |
DE-627 |
| 005 |
20240510195949.0 |
| 007 |
tu |
| 008 |
190711s2018 gw ||||| 00| ||ger c |
| 035 |
|
|
|a (DE-627)1669005364
|
| 035 |
|
|
|a (DE-599)KXP1669005364
|
| 035 |
|
|
|a (OCoLC)1158498961
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rda
|
| 041 |
|
|
|a ger
|
| 044 |
|
|
|c XA-DE-BW
|
| 082 |
0 |
4 |
|a 610
|q DE-101
|
| 084 |
|
|
|a 33
|2 sdnb
|
| 084 |
|
|
|a 33
|2 sdnb
|
| 100 |
1 |
|
|a Schneeweiss, Andreas
|d 1961-
|e VerfasserIn
|0 (DE-588)109972554
|0 (DE-627)632849630
|0 (DE-576)327251859
|4 aut
|
| 245 |
1 |
0 |
|a Pertuzumab (Perjeta)
|b hochwirksame Therapie beim HER2-positiven Mammakarzinom
|c Autoren Prof. Dr. med. Andreas Schneeweiss
|
| 264 |
|
1 |
|a Stuttgart
|a New York
|b Thieme
|c Dezember 2018
|
| 300 |
|
|
|a 14 Seiten
|b Illustrationen
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
| 338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
| 490 |
1 |
|
|a Drug report
|v Jahrgang 12.2018, Heft 17, Dezember
|
| 583 |
1 |
|
|a Archivierung/Langzeitarchivierung gewährleistet
|f PEBW
|h DE-24
|x XA-DE-BW
|2 pdager
|5 DE-31
|
| 830 |
|
0 |
|a Drug report
|v Jahrgang 12.2018, Heft 17, Dezember
|9 2018,17
|w (DE-627)882976974
|w (DE-576)485937689
|w (DE-600)2889371-2
|7 am
|
| 856 |
4 |
2 |
|u https://d-nb.info/1173638040/04
|m B:DE-101
|q application/pdf
|v 2020-12-02
|x Verlag
|3 Inhaltsverzeichnis
|
| 951 |
|
|
|a BO
|
| 992 |
|
|
|a 20200302
|
| 993 |
|
|
|a Book
|
| 994 |
|
|
|a 2018
|
| 998 |
|
|
|g 109972554
|a Schneeweiss, Andreas
|m 109972554:Schneeweiss, Andreas
|d 910000
|d 910400
|e 910000PS109972554
|e 910400PS109972554
|k 0/910000/
|k 1/910000/910400/
|p 1
|x j
|y j
|
| 999 |
|
|
|a KXP-PPN1669005364
|e 3601351528
|
| BIB |
|
|
|a Y
|
| JSO |
|
|
|a {"recId":"1669005364","person":[{"given":"Andreas","family":"Schneeweiss","display":"Schneeweiss, Andreas","roleDisplay":"VerfasserIn","role":"aut"}],"id":{"eki":["1669005364"]},"name":{"displayForm":["Autoren Prof. Dr. med. Andreas Schneeweiss"]},"type":{"bibl":"book"},"physDesc":[{"extent":"14 Seiten","noteIll":"Illustrationen"}],"origin":[{"dateIssuedKey":"2018","publisherPlace":"Stuttgart ; New York","dateIssuedDisp":"Dezember 2018","publisher":"Thieme"}],"language":["ger"],"relMultPart":[{"title":[{"title":"Drug report","title_sort":"Drug report"}],"language":["ger"],"origin":[{"dateIssuedDisp":"[2017-2019]","publisher":"Thieme","publisherPlace":"Stuttgart"}],"type":{"bibl":"serial"},"recId":"882976974","titleAlt":[{"title":"Thieme Diagnostik-Report"},{"title":"Diagnostik Report"}],"note":["Fortgesetzt als ungezählte Beilage bei den Hauptzeitschriften"],"dispAlt":"Drug report","pubHistory":["11. Jahrgang, Heft 2 (Februar 2017)-13. Jahrgang, Heft 11 (Juli 2019) ; 13. Jahrgang (August 2019)-13. Jahrgang (November 2019)"],"physDesc":[{"extent":"Bände","noteFormat":"27 cm"}],"id":{"zdb":["2889371-2"],"eki":["882976974"]},"part":{"number_sort":["2018,17"],"number":["Jahrgang 12.2018, Heft 17, Dezember"]},"disp":"Drug report"}],"title":[{"title_sort":"Pertuzumab (Perjeta)","subtitle":"hochwirksame Therapie beim HER2-positiven Mammakarzinom","title":"Pertuzumab (Perjeta)"}]}
|
| SRT |
|
|
|a SCHNEEWEISPERTUZUMAB2018
|
